[1]
“Endocrine Disruptors (EDs) regulatory waves: A frictional lens perspective on regulated and emerging markets”, Int. J. Pharm. Sci. Drug Res., vol. 13, no. 2, pp. 230–239, Mar. 2021, doi: 10.25004/IJPSDR.2021.130218.